Day: December 11, 2024

Dynocardia has received a $1 million NSF grant to enhance their unique computer vision-based motion-correction technology and expand the applications of its ViTrack® continuous non-invasive blood pressure (cNIBP) monitor

Dynocardia's proprietary computer-vision technology effectively identifies and compensates for movement artifacts. Overcoming these artifacts has long been a significant challenge...

Mana.bio Presents Broad Improvements to Systemic Lipid Nanoparticle Tolerability by Leveraging a Novel AI-Driven Safety Model

Mana's lung-targeting AI model initially yielded a highly-specific, lung-tropic LNPIterative in-silico / in-vitro cycles improved in-vivo potency by ~100X in 3-months Data...

error: Content is protected !!